Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (35)
Lisa E. Dumkow, Abigail C. Geyer & Lisa E. Davidson. (2023) Antimicrobial Stewardship at Transitions of Care. Infectious Disease Clinics of North America.
Crossref
Crossref
Margaret Pertzborn, Christina G. Rivera & Don Bambino Geno Tai. (2023) Taking the route less traveled: on the way to COpAT. Therapeutic Advances in Infectious Disease 10.
Crossref
Crossref
Taylor M. Epperson, Kiya K. Bennett, Katherine K. Kupiec, Kathy Speigel, Stephen B. Neely, Beth H. Resman-Targoff, Karen K. Kinney & Bryan P. White. (2023) Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center. Antimicrobial Stewardship & Healthcare Epidemiology 3:1.
Crossref
Crossref
Hester H. Stoorvogel, Marlies E. J. L. Hulscher, Heiman F. L. Wertheim, Ed P. F. Yzerman, Maarten Scholing, Jeroen A. Schouten & Jaap ten Oever. (2022) Current Practices and Opportunities for Outpatient Parenteral Antimicrobial Therapy in Hospitals: A National Cross-Sectional Survey. Antibiotics 11:10, pages 1343.
Crossref
Crossref
Kelsea Zukauckas, Russell J. Benefield, Michael Newman & Laura Certain. (2022) Why Bother? Lab Monitoring in Beta-Lactam Outpatient Parenteral Antimicrobial Therapy. Antimicrobial Agents and Chemotherapy 66:6.
Crossref
Crossref
Charnicia E. Huggins, Tae Eun Park, Eric Boateng & Cosmina Zeana. (2020) The Impact of a Standardized Discharge Process on 30-Day Readmissions for Patients on Outpatient Parenteral Antibiotic Treatment. Hospital Pharmacy 57:1, pages 107-111.
Crossref
Crossref
Eunjeong Heo, Yoonhee Choi, Hyung-sook Kim, Hyung Wook Namgung, Eunsook Lee, Euni Lee, Ju-Yeun Lee, Jongtak Jung, Eu Suk Kim, Hong Bin Kim & Kyoung-Ho Song. (2022) Current Status of Outpatient Parenteral Antimicrobial Therapy in Korea: Experience of a Single University-Affiliated Acute-Care Hospital. Infection & Chemotherapy 54.
Crossref
Crossref
Sarah A. Cummins, Cole Beeler, Eva Muloma & Sharon M. Erdman. (2021) Outcomes of Central Nervous System Infections Treated by an Outpatient Parenteral Antimicrobial Therapy Program in a Public Teaching Hospital. Infectious Diseases in Clinical Practice 29:2, pages e82-e87.
Crossref
Crossref
Christoph Kolja Boese, Philipp Lechler, Michael Frink, Michael Hackl, Peer Eysel & Christian Ries. (2020) Kostenanalyse stationärer und ambulanter intravenöser Antibiotikatherapie periprothetischer GelenkinfektionenCost analysis of inpatient versus outpatient intravenous antibiotic treatment for periprosthetic joint infections. Der Orthopäde 50:2, pages 150-158.
Crossref
Crossref
Toni Docherty, Jennifer J. Schneider & Joyce Cooper. (2020) Clinic- and Hospital-Based Home Care, Outpatient Parenteral Antimicrobial Therapy (OPAT) and the Evolving Clinical Responsibilities of the Pharmacist. Pharmacy 8:4, pages 233.
Crossref
Crossref
Kaylen Brzozowski, Rupak Datta, Joseph Canterino, Maricar Malinis & Manisha Juthani-Mehta. (2020) Adverse Events and Healthcare Utilization Associated With Outpatient Parenteral Antimicrobial Therapy Among Older Versus Younger Adults. Open Forum Infectious Diseases 7:10.
Crossref
Crossref
Robert J van de Peppel, Alexander Schauwvlieghe, Ruth Van Daele, Isabel Spriet, Jan W van't Wout, Roger J Brüggemann, Bart J A Rijnders, Bart J C Hendriks & Mark G J de Boer. (2020) Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B. Medical Mycology 58:7, pages 874-880.
Crossref
Crossref
Sara Jo Bugeja, Derek Stewart, Alison Strath & Helen Vosper. (2020) Human Factors approaches to evaluating outpatient parenteral antimicrobial therapy services: A systematic review. Research in Social and Administrative Pharmacy 16:5, pages 614-627.
Crossref
Crossref
Danielle L Palms & Jesse T Jacob. (2020) Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy. Clinical Infectious Diseases 70:1, pages 67-74.
Crossref
Crossref
Yasir Hamad, Michael A Lane, Susan E Beekmann, Philip M Polgreen & Sara C Keller. (2019) Perspectives of United States–Based Infectious Diseases Physicians on Outpatient Parenteral Antimicrobial Therapy Practice. Open Forum Infectious Diseases 6:10.
Crossref
Crossref
Ann L N Chapman, Sanjay Patel, Carolyne Horner, Helen Green, Achyut Guleri, Sara Hedderwick, Susan Snape, Julie Statham, Elizabeth Wilson, Mark Gilchrist & R Andrew Seaton. (2019) Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC-Antimicrobial Resistance 1:2.
Crossref
Crossref
Guillaume Binson, Claire Grignon, Gwenaël Le Moal, Pauline Lazaro, Jérémy Lelong, France Roblot, Nicolas Venisse & Antoine Dupuis. (2019) Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps. PLOS ONE 14:8, pages e0221391.
Crossref
Crossref
James Hatcher, Ceire Costelloe, Richard Cele, Anu Viljanen, Dunisha Samarasinghe, Giovanni Satta, Eimear Brannigan, Eoghan De Barra, Frances Sanderson & Mark Gilchrist. (2019) Factors associated with successful completion of outpatient parenteral antibiotic therapy (OPAT): A 10-year review from a large West London service. International Journal of Antimicrobial Agents 54:2, pages 207-214.
Crossref
Crossref
Christoph Kolja Boese, Philipp Lechler, Michael Frink, Michael Hackl, Peer Eysel & Christian Ries. (2019) Cost-analysis of inpatient and outpatient parenteral antimicrobial therapy in orthopaedics: A systematic literature review. World Journal of Clinical Cases 7:14, pages 1825-1836.
Crossref
Crossref
Jeremy D Young, Rima Abdel-Massih, Thomas Herchline, Lewis McCurdy, Kay J Moyer, John D Scott, Brian R Wood & Javeed Siddiqui. (2019) Infectious Diseases Society of America Position Statement on Telehealth and Telemedicine as Applied to the Practice of Infectious Diseases. Clinical Infectious Diseases 68:9, pages 1437-1443.
Crossref
Crossref
Ester Steffens, Charlotte Quintens, Inge Derdelinckx, Willy E. Peetermans, Johan Van Eldere, Isabel Spriet & Annette Schuermans. (2018) Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?. Infection 47:2, pages 169-181.
Crossref
Crossref
Nikolas Rae, Claire Kenny & Eavan G. Muldoon. (2019)
Can intravenous antifungal therapy be safely used in the outpatient parenteral antimicrobial therapy (
OPAT
) setting?
. Mycoses 62:3, pages 196-203.
Crossref
Crossref
Roos Wijnakker, Loes E. Visser, Emile F. Schippers, Leo G. Visser, Nathalie D. van Burgel & Cees van Nieuwkoop. (2018) The impact of an infectious disease expert team on outpatient parenteral antimicrobial treatment in the Netherlands. International Journal of Clinical Pharmacy 41:1, pages 49-55.
Crossref
Crossref
Victoria Huang, Jorg J. Ruhe, Polina Lerner & Marianna Fedorenko. (2018) Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study. BMC Pharmacology and Toxicology 19:1.
Crossref
Crossref
Omar Mansour, Jacqueline Heslin & Jennifer L Townsend. (2018) Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates. Journal of Antimicrobial Chemotherapy 73:11, pages 3181-3188.
Crossref
Crossref
Mohsen Vazirian, Jason M. Jerry, Nabin K. Shrestha & Steven M. Gordon. (2018) Outcomes of Outpatient Parenteral Antimicrobial Therapy in Patients With Injection Drug Use. Psychosomatics 59:5, pages 490-495.
Crossref
Crossref
Marion Le Maréchal, Gianpiero Tebano, Annelie A Monnier, Niels Adriaenssens, Inge C Gyssens, Benedikt Huttner, Romina Milanič, Jeroen Schouten, Mirjana Stanić Benić, Ann Versporten, Vera Vlahović-Palčevski, Veronica Zanichelli, Marlies E Hulscher, Céline Pulcini, Bojana Beović, Luis Bavestrello, Jon Cohen, Pieter-Jan Cortoos, Harpal Dhillon, Richard Drew, Prabhavathi Fernandes, David Findlay, Ian Friedland, Ian Gould, Lauri Hicks, Christopher Longshaw, Carl Llor, Allison McGeer, Iruka N Okeke, Diamantis Plachouras, Garyfallia Poulakou, John H Rex, Thomas Tängdén, Laura Trolle Saust, Claudine Richon, France Roblot, Robert Vander Stichele, Marcel Verweij & Heiman Wertheim. (2018) Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure. Journal of Antimicrobial Chemotherapy 73:suppl_6, pages vi40-vi49.
Crossref
Crossref
Helen T D’Couto, Gregory K Robbins, Kevin L Ard, Sarah E Wakeman, Justin Alves & Sandra B Nelson. (2018) Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy. Open Forum Infectious Diseases 5:5.
Crossref
Crossref
C. Triffault-Fillit, T. Ferry, T. Perpoint, L. Adélaïde, S. Le Ngoc Tho, F. Ader, C. Chidiac & F. Valour. (2018) Outpatient parenteral antibiotic therapy: Evaluation of practices and limits of use in rural areas in France. Médecine et Maladies Infectieuses 48:2, pages 130-135.
Crossref
Crossref
Teresa M. Wozniak. (2018) Clinical management of drug-resistant bacteria in Australian hospitals: An online survey of doctors' opinions. Infection, Disease & Health 23:1, pages 41-48.
Crossref
Crossref
Sara C Keller, Deborah Williams, Mitra Gavgani, David Hirsch, John Adamovich, Dawn Hohl, Ayse P Gurses & Sara E Cosgrove. (2018) Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy. Clinical Infectious Diseases 66:1, pages 11-19.
Crossref
Crossref
Shu J Tan, Paul R Ingram, Alison J Rothnie, Timothy J Whitmore, James O Robinson, Jillian B Hatch, Claire M Italiano & Christopher H Heath. (2017) Successful outpatient parenteral antibiotic therapy delivery via telemedicine. Journal of Antimicrobial Chemotherapy 72:10, pages 2898-2901.
Crossref
Crossref
E D Mitchell, C Czoski Murray, D Meads, J Minton, J Wright & M Twiddy. (2017)
Clinical and cost-effectiveness, safety and acceptability of
c
ommunity
i
ntra
v
enous
a
ntibiotic
s
ervice models: CIVAS systematic review
. BMJ Open 7:4, pages e013560.
Crossref
Crossref
Monica Schmidt, Bevin Hearn, Michael Gabriel, Melanie D. Spencer & Lewis McCurdy. (2017) Predictors of Unplanned Hospitalization in Patients Receiving Outpatient Parenteral Antimicrobial Therapy Across a Large Integrated Healthcare Network. Open Forum Infectious Diseases 4:2.
Crossref
Crossref
Jane Minton, Carolyn Czoski Murray, David Meads, Stephane Hess, Armando Vargas-Palacios, Elizabeth Mitchell, Judy Wright, Claire Hulme, David K Raynor, Angela Gregson, Philip Stanley, Kate McLintock, Rachel Vincent & Maureen Twiddy. (2017) The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy. Health Services and Delivery Research 5:6, pages 1-272.
Crossref
Crossref